ARTICLE SUMMARY:
A robotics start-up’s miniaturized system offers efficiency and ease of use for a variety of needle-based procedures.
As the availability of skilled surgeons and specialists continues to shrink relative to the population of patients in need, robotic solutions have become one of the fastest growing and most impactful subsets of medtech. Yet, as Mendaera CEO and co-founder Josh DeFonzo learned firsthand, robots can be quite challenging to develop in terms of scaling and supply chain, and often entail a high cost to manufacture, creating a barrier to entry for innovators without massive resources.
